Viewing Study NCT00305903


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-25 @ 4:45 PM
Study NCT ID: NCT00305903
Status: COMPLETED
Last Update Posted: 2007-12-21
First Post: 2006-03-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module